Kiora Pharmaceuticals (KPRX) Cash from Investing Activities (2015 - 2026)

Kiora Pharmaceuticals (KPRX) has 8 years of Cash from Investing Activities data on file, last reported at $5.4 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 102.07% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (up 185.82% YoY) and the FY2025 annual result came in at $14.4 million, up 163.66% from the prior year.
• Cash from Investing Activities improved to $5.4 million in Q1 2026, from $5.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $5.7 million in Q3 2025 to a low of -$21.2 million in Q2 2024.
• A 4-year average of -$314289.9 and a median of $664172.0 in 2025 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2025 — Cash from Investing Activities jumped 1008.21% — and 2026, when it jumped 102.07%.
• Tracing KPRX's Cash from Investing Activities over 4 years: stood at $6375.0 in 2022, then soared by 7471.5% to $482683.0 in 2024, then jumped by 1008.21% to $5.3 million in 2025, then climbed by 0.97% to $5.4 million in 2026.
• The last three Cash from Investing Activities figures came in at $5.4 million (Q1 2026), $5.3 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.